TTK Healthcare Ltd (TTKHLTCARE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by TTK Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
TTK Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 30 Oct 2026, 6:46 pm
Outcome of Board Meeting for Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026.
Outcome · 30 Oct 2026, 6:44 pm
TTK Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 23,338 (+14.6% YoY | -9.4% QoQ) ■ EBITDA: 375 (-29.8% YoY | -74.6% QoQ) ■ EBITDA Margin (%): 1.6 (-102 bps YoY | -412 bps QoQ) ■ PAT: 22,297 (+993.7% YoY | +947.8% QoQ) ■ EPS (INR): 157.8 (+993.6% YoY | +947.8% QoQ) TTK Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) Segmental Performance Animal Welfare ■ Revenue: 4,121 (+16.2% YoY | +14.8% QoQ) ■ EBIT: 286 (-9.6% YoY | +148.8% QoQ) ■ EBIT Margin (%): 6.9 (-198 bps YoY | +374 bps QoQ) Consumer Products ■ Revenue: 5,456 (-3.0% YoY | -29.2% QoQ) ■ EBIT: -40.7 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBIT Margin (%): -0.7 (Profit to Loss YoY | Profit to Loss QoQ) Medical Devices ■ Revenue: 2,934 (+14.7% YoY | -12.7% QoQ) ■ EBIT: 501 (-17.3% YoY | -34.0% QoQ) ■ EBIT Margin (%): 17.1 (-663 bps YoY | -550 bps QoQ) Protective Devices ■ Revenue: 6,557 (+34.3% YoY | -9.8% QoQ) ■ EBIT: -75.8 (+92.6% YoY | Profit to Loss QoQ) ■ EBIT Margin (%): -1.2 (+1983 bps YoY | Profit to Loss QoQ) Foods ■ Revenue: 4,262 (+14.2% YoY | +11.5% QoQ) ■ EBIT: 452 (+18.8% YoY | +9.5% QoQ) ■ EBIT Margin (%): 10.6 (+41 bps YoY | -19 bps QoQ) Others ■ Revenue: 7.8 (-22.7% YoY | -36.1% QoQ) ■ EBIT: 8.6 (-19.6% YoY | -20.4% QoQ) ■ EBIT Margin (%): 111 (+424 bps YoY | +2186 bps QoQ)
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 30 Oct 2026, 5:30 am
TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Board Meeting to be held on ....
Intimation · 30 Oct 2026, 5:30 am
TTK Healthcare Board Meeting Scheduled for 30th Oct'26 to Approve Q2 Results TTK Healthcare Limited announced that its Board of Directors will meet on 30th Oct'26 to consider and approve the unaudited financial results for the second quarter ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company shares by designated persons and their immediate relatives remains closed from 1st Oct'26 to 1st Nov'26 (both days inclusive).
Announcement under Regulation 30 of SEBI LODR Regulations.
Others (Uncategorized) · 04 Sept 2026, 8:20 pm
TTK Healthcare Completes Sale of EVA and Good Home Brands for Rs 256 Crore TTK Healthcare Limited completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises Private Limited pursuant to definitive agreements entered on 23rd Jul'26. The company received the full cash consideration of Rs 256 crore plus applicable GST on 4th Sep'26, marking the successful closing and completion of the transaction.
Appointment of Tax Auditor of the Company
Change in Auditor · 02 Sept 2026, 8:07 pm
Intimation from M/s Aiyar & Co. regarding their inability to continue as Tax Auditors
Others (Uncategorized) · 27 Aug 2026, 9:16 pm
TTK Healthcare's Tax Auditor Withdraws for FY26 Due to ICAI Ineligibility TTK Healthcare (NSE: TTKHLTCARE) announced its Tax Auditor, M/s. Aiyar & Co., has withdrawn from the FY26 tax audit assignment effective 26 Aug'26. The withdrawal is due to the auditor's Peer Review Certificate, issued by the Institute of Chartered Accountants of India (ICAI), not permitting them to sign audit reports for listed companies. The company’s Audit Committee and Board will now initiate the process to appoint a new Tax Auditor for the financial year 2025-26. This change is a regulatory compliance issue, not performance-related.
Outcome of Board Meeting
Outcome · 06 Aug 2026, 6:54 pm
TTK Healthcare Q1 FY27 PAT Jumps 63.7% YoY on Strong Revenue Growth TTK Healthcare reported a strong Q1 FY27 performance with net profit rising 63.7% YoY to ₹212.8M. Revenue from operations for the quarter ended 30 Jun'26 grew 13.7% YoY to ₹2.58B, driven by Protective Devices (+37.9%) and Consumer Products (+1.8%). Profit before tax increased 63.5% YoY to ₹288.6M. Basic EPS stood at ₹15.06, a significant increase from ₹9.20 in the prior year's quarter. The Protective Devices segment returned to profitability, posting a profit of ₹61.3M versus a loss of ₹54.4M YoY.
Outcome of Board Meeting
Outcome · 06 Aug 2026, 6:49 pm
TTK Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 25,756 (+13.7% YoY | +18.2% QoQ) ■ EBITDA: 1,474 (+450.7% YoY | +33.6% QoQ) ■ EBITDA Margin (%): 5.7 (+454 bps YoY | +66 bps QoQ) ■ PAT: 2,128 (+63.7% YoY | -2.2% QoQ) ■ EPS (INR): 15.1 (+63.7% YoY | -2.2% QoQ) TTK Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) Segmental Performance Animal Welfare ■ Revenue: 3,590 (+12.6% YoY | +0.2% QoQ) ■ EBIT: 115 (-50.8% YoY | -53.1% QoQ) ■ EBIT Margin (%): 3.2 (-414 bps YoY | -365 bps QoQ) Consumer Products ■ Revenue: 7,703 (+1.9% YoY | +42.7% QoQ) ■ EBIT: 284 (+126.3% YoY | -46.2% QoQ) ■ EBIT Margin (%): 3.7 (+203 bps YoY | -611 bps QoQ) Medical Devices ■ Revenue: 3,359 (+16.4% YoY | +24.7% QoQ) ■ EBIT: 758 (-6.0% YoY | +117.0% QoQ) ■ EBIT Margin (%): 22.6 (-538 bps YoY | +960 bps QoQ) Protective Devices ■ Revenue: 7,269 (+37.9% YoY | +19.2% QoQ) ■ EBIT: 613 (Loss to Profit YoY | -1.9% QoQ) ■ EBIT Margin (%): 8.4 (Loss to Profit YoY | -182 bps QoQ) Foods ■ Revenue: 3,822 (+2.6% YoY | -4.9% QoQ) ■ EBIT: 412 (+40.2% YoY | +25.2% QoQ) ■ EBIT Margin (%): 10.8 (+289 bps YoY | +260 bps QoQ) Others ■ Revenue: 12.2 (+32.8% YoY | +34.1% QoQ) ■ EBIT: 10.8 (+38.6% YoY | +21.7% QoQ) ■ EBIT Margin (%): 88.9 (+374 bps YoY | -909 bps QoQ)
TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Board Meeting Intimation
Intimation · 06 Aug 2026, 5:30 am
TTK Healthcare Board Meeting Scheduled for Q1FY27 Results TTK Healthcare has scheduled a Board of Directors meeting on Aug 06, '26, to consider and approve the unaudited financial results for the first quarter ending Jun 30, '26. In compliance with insider trading regulations, the trading window for designated persons and their immediate relatives is closed from Jul 01, '26, to Aug 08, '26, inclusive.
Voting Results of the 68th Annual General Meeting
Annual General Meeting · 24 Jul 2026, 11:52 pm
Chairman''s Speech - 68th Annual General Meeting
Annual General Meeting · 24 Jul 2026, 8:16 pm
Outcome of the 68th Annual General Meeting
Annual General Meeting · 24 Jul 2026, 8:12 pm
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular dated July 11, 2023
Others (Uncategorized) · 23 Jul 2026, 6:24 pm
TTK Healthcare Sells "EVA" and "Good Home" Brands to Wipro for Rs. 256 Crores TTK Healthcare's Board approved the sale of its "EVA" and "Good Home" brands to Wipro Enterprises Private Limited for a consideration of Rs. 256 crores on Jul 23, '26. The brands generated Rs. 148 crores in revenue for FY26, representing 17% of the company's total turnover. The transaction is not a related-party deal and is expected to be completed by Sep 30, '26, subject to customary closing conditions. This divestment marks a strategic move to exit a key consumer brands division.
Board Meeting Outcome
Outcome · 23 Jul 2026, 6:23 pm
TTK Healthcare Divests "EVA" and "Good Home" Brands to Wipro TTK Healthcare's board approved the sale of its "EVA" and "Good Home" brands to Wipro Enterprises for Rs. 256 crores on 23 Jul '26. The divested brands generated Rs. 148 crores in revenue for FY26, representing 17% of the company's total turnover. The transaction, which is not a related-party deal, is expected to be completed by 30 Sep '26, subject to customary closing conditions. This strategic divestment marks a significant portfolio restructuring for TTK Healthcare, unlocking value from its consumer brands division.
Business Responsibility and Sustainability Reporting (BRSR)
Others (Uncategorized) · 27 Jun 2026, 8:16 pm
TTK Healthcare Submits Business Responsibility and Sustainability Report for FY25-26 TTK Healthcare filed its Business Responsibility & Sustainability Report for FY25-26 on 27 Jun'26. The report details the company's FY26 standalone performance, which includes Rs. 14.13cr in paid-up capital and CSR-applicable turnover of Rs. 85,728.11 lakhs with a net worth of Rs. 1,09,517.26 lakhs. Key product segments by turnover were Male Contraceptives (25.26%) and Food Products (17.63%). Permanent employee turnover rate for FY26 was 23.69%. The company reported exports contributing 6.41% to total turnover and did not report any holding or subsidiary companies.
Annual Report for FY 2025-26 with 68th AGM Notice
Annual General Meeting · 27 Jun 2026, 8:12 pm
Annual Report 2025-26
Annual Report · 27 Jun 2026, 8:08 pm
Annual Report for Financial Year 2025-26
Others (Uncategorized) · 27 Jun 2026, 8:06 pm
Record Date
Others · 03 Jun 2026, 8:17 pm
TTK Healthcare Sets AGM and Dividend Record Date TTK Healthcare has scheduled its 68th Annual General Meeting (AGM) for 12:00 noon on Fri, Jul 24, 2026, to be held via video conferencing. The company also announced Fri, Jul 17, 2026, as the Record Date for determining shareholder voting rights and for the declaration of a dividend. Investors must hold shares by this date to be eligible for the dividend payout.
Announcement under Regulation 30 of SEBI LODR.
Others (Uncategorized) · 01 Jun 2026, 11:39 pm
TTK Healthcare Pays Penalty on Customs Duty Differential TTK Healthcare disclosed a customs duty reclassification on imported products, raising the duty from 7.5% to 10%. The company has already paid the 2.5% differential duty plus interest. Following insistence from the Customs Department, TTK Healthcare has now also paid a penalty of Rs. 9,93,320, equivalent to 15% of the differential duty, on Jun 01, '26, to close the matter. The company stated the issue relates only to a change in product classification with no suppression of information.
Outcome of Board Meeting
Financial Result · 30 May 2026, 8:57 pm
TTK Healthcare Board Approves FY26 Results, Dividend, and Chairman Reappointment TTK Healthcare's Board approved FY26 results on 30 May'26. Q4FY26 PAT was Rs. 2,176.21 lakhs, up 34.8% YoY, while revenue grew 14.5% YoY to Rs. 21,798.47 lakhs. For the full year, PAT declined 19.6% YoY to Rs. 6,568.05 lakhs, though revenue rose 6.9% YoY to Rs. 85,728.11 lakhs. The Board recommended a dividend of Rs. 10/- per share (100%) for FY26. Additionally, it approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further 5-year term.
Outcome of Board Meeting
Annual General Meeting · 30 May 2026, 7:23 pm
TTK Healthcare Board Approves FY26 Results, Recommends Rs. 10 Dividend TTK Healthcare board approved Q4FY26 and full-year results on May 30, '26. For FY26, revenue from operations grew 7.0% YoY to Rs. 85,728.11 lakhs, while PAT declined 19.6% to Rs. 6,568.05 lakhs. Q4FY26 PAT was Rs. 2,176.21 lakhs, up 34.8% YoY. The board recommended a final dividend of Rs. 10 per share (100%) for FY26. Additionally, the board approved the reappointment of Mr. T T Raghunathan as Executive Chairman for five years, effective Nov 01, '26, and scheduled the 68th AGM for Jul 24, '26.
Announcement under Regulation 30 of SEBI LODR.
Dividend · 30 May 2026, 7:20 pm
TTK Healthcare FY26 Results: Net Profit Declines, Rs. 10 Dividend Declared TTK Healthcare's Board approved results for the quarter and year ended 31 Mar'26. For FY26, revenue from operations grew 6.96% YoY to Rs. 85,728.11 lakhs, while Profit After Tax declined 19.56% YoY to Rs. 6,568.05 lakhs. Q4FY26 PAT stood at Rs. 2,176.21 lakhs, a 34.76% YoY increase. The Board recommended a dividend of Rs. 10 per share (100%). Additionally, the Board approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a 5-year term effective 01 Nov'26.
Announcement under Regulation 30 of SEBI (LODR), 2015
Change in Management · 30 May 2026, 7:19 pm
TTK Healthcare Reports FY26 Results, Recommends Rs.10 Dividend TTK Healthcare's Board approved FY26 results on 30 May'26. For Q4FY26, revenue from operations was Rs. 21,798.47 lakhs and PAT stood at Rs. 2,176.21 lakhs. Full-year FY26 revenue reached Rs. 85,728.11 lakhs with PAT of Rs. 6,568.05 lakhs, resulting in a Basic EPS of Rs. 46.48. The Board recommended a dividend of Rs. 10 per share (100%). Additionally, the Board approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further 5-year term, effective 01 Nov'26.